We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

Back to rankings

49 hedge funds and large institutions have $14.6M invested in Neos Therapeutics, Inc in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 11

9% less funds holding

Funds holding: 54 → 49 (-5)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

55% less capital invested

Capital invested by funds: $32.7M → $14.6M (-$18.1M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $8K

Holders
49
Holders Change
-5
Holders Change %
-9.26%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
11
Reduced
11
Closed
7
Calls
–
Puts
$8K
Net Calls
-$8K
Net Calls Change
+$15K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$47.2K
2
Citadel Advisors
Citadel Advisors
Florida
+$47.1K
3
Goldman Sachs
Goldman Sachs
New York
+$44.9K
4
Millennium Management
Millennium Management
New York
+$31.9K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$29.1K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$1.4M
2
Russell Investments Group
Russell Investments Group
United Kingdom
-$874K
3
Boston Partners
Boston Partners
Massachusetts
-$347K
4
SCM
Stonepine Capital Management
Oregon
-$232K
5
JP Morgan Chase
JP Morgan Chase
New York
-$144K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$3.52M -$232K -168,743 -3%
NCM
2
Nantahala Capital Management
Connecticut
$3.46M – – –
Goldman Sachs
3
Goldman Sachs
New York
$1.94M +$44.9K +32,698 +1%
SFM
4
Sphera Funds Management
Israel
$1.88M -$1.4M -1,021,263 -29%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.32M – – –
Renaissance Technologies
6
Renaissance Technologies
New York
$526K +$47.2K +34,375 +5%
BlackRock
7
BlackRock
New York
$396K +$1.61K +1,170 +0.2%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$255K -$29K -21,120 -6%
DM
9
Deerfield Management
New York
$241K – – –
BCM
10
Bridgeway Capital Management
Texas
$131K -$48.1K -35,000 -17%
Jacobs Levy Equity Management
11
Jacobs Levy Equity Management
New Jersey
$107K +$29.1K +21,138 +17%
BGIM
12
Brandywine Global Investment Management
Pennsylvania
$93K +$973 +708 +0.6%
Northern Trust
13
Northern Trust
Illinois
$90K +$27.2K +19,767 +20%
HAIM
14
Hunter Associates Investment Management
Pennsylvania
$75K – – –
PCM
15
Proxima Capital Management
New York
$69K -$108K -78,594 -46%
Wells Fargo
16
Wells Fargo
California
$63K +$21.4K +15,570 +23%
WA
17
Wealthstar Advisors
Texas
$55K – – –
Millennium Management
18
Millennium Management
New York
$39K +$31.9K +23,211 +80%
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$29K – – –
Citadel Advisors
20
Citadel Advisors
Florida
$26K +$47.1K +34,271 New
WG
21
Winton Group
United Kingdom
$22K -$28.8K -20,947 -42%
BWM
22
BCS Wealth Management
Tennessee
$22K – – –
William Blair & Company
23
William Blair & Company
Illinois
$20K +$14.4K +10,500 +64%
AIM
24
Alambic Investment Management
California
$19K -$37.2K -27,044 -52%
ACM
25
Allred Capital Management
Texas
$18K – – –
1
2 3

NEOS Hedge Fund Activity: Q1 2020 in Review

49 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q1 2020, worth a combined $14.6M — down 55% from $32.7M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of NEOS and 5 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 11 added.

The largest buyer was Renaissance Technologies, adding an estimated $47.2K. The largest seller was Sphera Funds Management, cutting an estimated $1.4M.

  • 49 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q1 2020, down from 54 in Q4 2019.
  • Funds reported $14.6M of Neos Therapeutics, Inc stock for Q1 2020, down 55% quarter-over-quarter.
  • 5 funds opened new Neos Therapeutics, Inc positions in Q1 2020 and 7 closed out, a net change of -2 holders.
  • The largest Neos Therapeutics, Inc buyer in Q1 2020 was Renaissance Technologies, an estimated $47.2K added.
  • The largest Neos Therapeutics, Inc seller in Q1 2020 was Sphera Funds Management, an estimated $1.4M sold.

Based on aggregated 13F filings for Q1 2020.